StockVS

FONAR Corporation (FONR) 주식 분석

의료

FONAR Corporation

$18.91

+$0.02 (+0.08%)

최종 업데이트: 2026년 5월 26일

가격 추이

분석

회사 개요

FONAR Corporation is a specialized manufacturer dedicated to the design, production, sales, and maintenance of magnetic resonance imaging (MRI) scanners used for diagnosing human diseases, medical abnormalities, and physical injuries within the United States. The company operates within the Healthcare sector, specifically in the Diagnostics & Research industry, which positions it as a critical supplier of advanced medical imaging technology essential for clinical diagnostic workflows. As of the latest data, the company carries a market capitalization of $117.26M, generates annual revenue of $106.03M, and employs a workforce of 535 individuals to support its operations. These financial metrics indicate that FONAR functions as a mid-sized enterprise with a significant revenue base relative to its market cap, suggesting a valuation that is tightly aligned with its current earnings generation rather than speculative growth premiums.

재무 건전성

FONAR Corporation reported a trailing twelve-month revenue of $106.03M, which resulted in a net income of $7.19M and an EBITDA of $15.05M, highlighting a distinct gap between top-line revenue and bottom-line profit that reflects the substantial cost of goods sold and operating expenses inherent in manufacturing complex medical equipment. The company generated $2.44M in free cash flow, a figure that underscores a conservative approach to capital allocation and provides the management team with financial flexibility to manage operational cash needs without relying heavily on external financing. Profitability analysis reveals a gross margin of 40.8%, an operating margin of 11.7%, and a profit margin of 7.1%, indicating that while the manufacturing process retains a healthy portion of sales revenue, significant costs are deducted at the operating level before arriving at the final net profit. The balance sheet shows a cash position of $53.10M compared to total debt of $39.80M, resulting in a debt-to-equity ratio of 24.44, which suggests a leveraged capital structure where debt obligations exceed equity capitalization despite the presence of substantial liquid assets. Liquidity is exceptionally strong with a current ratio of 10.00, implying that the company holds ten times the current assets necessary to cover its short-term liabilities, thereby minimizing the risk of a liquidity crisis. Return metrics show a return on equity of 6.0% and a return on assets of 3.2%, which reveals that the company generates modest returns relative to the shareholders' equity and the total asset base, indicating a need for efficient capital deployment to enhance management effectiveness.

밸류에이션 평가

The valuation of FONAR Corporation is characterized by a trailing P/E ratio of 16.18, while a forward P/E ratio is not available in the current dataset, a situation that implies analysts may not be projecting significant near-term earnings acceleration or that the market is pricing in stability rather than rapid earnings expansion. The price-to-book ratio stands at 0.69, indicating that the market values the company at less than one dollar for every dollar of book value, which suggests the stock trades at a discount relative to its tangible asset base rather than commanding a premium for intangible growth prospects. Alternative valuation metrics further illustrate this positioning, with a price-to-sales ratio of 1.11 and an EV/EBITDA multiple of 6.29, suggesting that investors are paying slightly more than one dollar of revenue for the business and valuing earnings at a conservative multiple that aligns with cyclical or mature industrial sectors. Price momentum analysis shows a 52-week high of $18.86 and a 52-week low of $12.00, meaning the current trading price sits at a level that reflects a consolidation phase roughly 22% below the recent peak, assuming the current price remains within the observed volatility band. The stock exhibits a beta of 0.99, which indicates that the share price volatility is nearly identical to the broader market benchmark, suggesting the asset does not offer significant defensive downside protection nor aggressive upside beta exposure during market fluctuations.

Growth & Income

FONAR Corporation has demonstrated modest expansion with a revenue growth rate of 2.4% and an earnings growth rate of 1.1% year-over-year, indicating that earnings are growing at a slower pace than revenue, which typically implies that cost pressures or margin compression are offsetting the benefits of top-line expansion. The company does not pay dividends, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, which signals that management chooses to retain all net income to fund operations, R&D, or balance sheet strengthening rather than distributing cash to shareholders. This reinvestment strategy is consistent with a capital-intensive manufacturing business where growth capital is required to maintain technological relevance in the MRI scanner market. The overall growth and income profile presents a picture of a mature, non-dividend-paying company with single-digit growth rates and a focus on operational stability rather than aggressive capital return or explosive earnings acceleration.

동종업체 비교

FONAR Corporation (FONR) 은(는) 진단 및 연구 산업에서 운영됩니다. 시가총액 기준으로 가장 가까운 동종업체와의 비교는 다음과 같습니다:

기업명 티커 시가총액 PER
FONAR Corporation FONR $119.06M 18.9
Thermo Fisher Scientific Inc. TMO $166.55B 24.6
Danaher Corporation DHR $122.31B 33.4
IDEXX Laboratories, Inc. IDXX $43.95B 41.0

진단 및 연구 산업 평균 PER은 32.5배입니다. FONAR Corporation의 PER은 18.9입니다.

이 분석은 AI가 생성한 것으로 정보 제공 목적으로만 사용되며 투자 조언이 아닙니다. 데이터가 지연되거나 부정확할 수 있습니다. 투자 결정을 내리기 전에 항상 직접 조사하고 자격을 갖춘 재무 상담사와 상담하세요.

FONAR Corporation 소개

FONAR Corporation, together with its subsidiaries, engages in the designing, manufacturing, selling, and servicing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases, abnormalities, other medical conditions, and injuries in the United States. It operates in two segments: Medical Equipment, and Physician Management and Diagnostic Services. The company offers an Upright MRI scanner, which allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. It also provides non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with legal and regulatory matters, and development and implementation of practice growth and marketing strategies. In addition, the company owns and operates diagnostic imaging facilities. The company markets its scanners to private diagnostic imaging centers and hospital outpatient imaging facilities. FONAR Corporation was founded in 1978 and is based in Melville, New York.

회사 설명은 영어로 표시됩니다.

웹사이트 방문 →

주요 지표

시가총액
$119.06M
PER
18.91
52주 최고가
$18.95
52주 최저가
$13.62
평균 거래량
51.78K

데이터는 yfinance를 통해 Yahoo Finance에서 제공됩니다. 매일 업데이트.

기업 정보

거래소
NASDAQ
국가
United States
직원 수
535